AI in Pharma & MedTech

Artificial intelligence (AI) is transforming industries and daily life worldwide. As AI technologies evolve rapidly, governments are working to establish clear rules to ensure these innovations are safe, ethical, and respect fundamental rights. The European Union (EU) is at the forefront of this effort, developing a regulatory framework to govern AI use within its member states.

Bringing a medical device to market is a journey filled with regulatory checkpoints, documentation, and strategic decisions. As someone deeply involved in regulatory affairs, I understand how daunting this process can be, especially for biotech and SME companies striving to innovate while ensuring patient safety. The medical device approval process is not just a bureaucratic hurdle; it is a critical pathway that ensures every device meets stringent standards before reaching p

Navigating the regulatory landscape for medical devices in Europe can feel daunting. However, with the right approach and clear understanding, it becomes a manageable process that opens doors to one of the world’s most significant healthcare markets. I want to share practical insights and step-by-step guidance to help you confidently move through the process of registering medical devices in Europe. This will empower your company to bring innovative products to patients faste

Navigating the UK medical device market can be a complex journey. For biotech and SME companies, understanding the regulatory landscape is crucial to efficiently and safely bringing innovative products to patients. As someone deeply involved in this field, I know that medical device entry consulting is not just about ticking boxes; it’s about creating a strategic pathway that accelerates market access while ensuring compliance and patient safety.

Navigating the complex regulatory compliance landscape in the UK is a critical challenge for biotech and SME companies in the medical device and pharmaceutical sectors. As someone deeply involved in this field, I understand how essential it is to have a trusted partner who can guide you through the intricacies of regulations, ensuring your innovations reach patients safely and efficiently. Regulatory affairs play a pivotal role in this process, acting as the bridge between yo

Why FDA Compliance Consulting is Essential for UK Biotech and SME Companies. For biotech and SME companies, resources are often limited, and regulatory missteps can be costly. FDA compliance consulting offers tailored support that aligns with your business goals and product innovation timelines.

The EU AI Act (Artificial Intelligence Act Regulation EU 2024/1689), which came into force on 1 August 2024, establishes a harmonised framework for regulating AI systems. It impacts the use of AI in medical settings, particularly when integrated with the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR).

In this article, we will explore how AI is reshaping the pharmaceutical landscape and examine its implications for the workforce, presenting a balanced view on the potential benefits and challenges ahead.

Navigating the Future of Artificial Intelligence (AI) into Neurotechnology and medical technology (MedTech) is poised to revolutionise healthcare, offering unprecedented diagnostic and therapeutic capabilities.

The convergence of artificial intelligence and pharmaceutical innovation is no longer a distant vision; it’s today’s reality. With a projected market size of $116.49 billion by the end of 2025 and a 27% compound annual growth rate (CAGR), AI in pharma is reshaping everything from drug discovery to diagnostics.

In 2025, manufacturers of AI-powered medical devices face a new regulatory reality. The European Union has introduced the Artificial Intelligence Act (AIA). If your device falls under the Medical Device Regulation (MDR) or the In Vitro Diagnostic Regulation (IVDR), the AIA is mandatory. It’s now a core part of your compliance strategy.

In today's fast-paced world, technology is making remarkable changes across many sectors. Machine learning (ML) frameworks stand out as a...

In the fast-paced world of drug discovery, artificial intelligence (AI) has become essential, transforming the way researchers identify...

The rapid growth of machine learning (ML) in recent years has introduced new possibilities in healthcare. These advancements offer the...

The rapid growth of technology in healthcare has opened new doors for innovation, especially in digital health software. Developers are...

The digital health landscape is evolving quickly, thanks to advances in technology like artificial intelligence (AI) and machine learning...

AI in Pharma: almost half a century old, news. AI didn’t crash into pharma. It drifted in, slowly, quietly, and no one looked twice. It’s been part of the story for nearly 50 years.